AbelZeta to Attend 43rd Annual J.P. Morgan Healthcare Conference and Join Panel at 8th Annual BFC Healthcare Conference | PR Newswire [Video]

, /PRNewswire/ — AbelZeta Pharma, Inc. (“AbelZeta” or the “Company”), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic products, will attend  the 43^rd Annual J.P. Morgan Healthcare Conference on January 13-16, 2025, in San Francisco, CA, and host meetings showcasing the Company’s recent accomplishments and sharing strategic plans moving forward. The Company’s Chairman and CEO, Tony (Bizuo) Liu, has also been invited as a panel speaker  at the 8^th Annual BFC Global Healthcare BD and Investment Conference on Sunday, January 12, 2025.

About AbelZeta Pharma, Inc.

AbelZeta is a global clinical-stage biopharmaceutical company with Centers of Excellence in Rockville, Maryland and Shanghai, China. AbelZeta is focused on developing innovative and proprietary cell-based therapeutic products and is committed to ushering in bespoke treatments that harness the body’s own immune system to fight against hematological malignancies and solid tumors, as well as inflammatory and immunological diseases. AbelZeta advances …